Ubs Group Ag Precigen, Inc. Transaction History

Ubs Group Ag

$611 Billion
Q3 2025

A detailed history of Ubs Group Ag transactions in Precigen, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 630,604 shares of PGEN stock, worth $2.91 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

630,604

Previous 356,395 76.94%

Holding current value

$2.91 Million

Previous $506,000 309.88%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$1.43 - $4.76 $392,118 - $1.31 Million	274,209 Added 76.94%	630,604 $2.07 Million
Q2 2025 Aug 14, 2025	SELL	$1.17 - $1.62 $182,417 - $252,577	-155,912 Reduced 30.43%	356,395 $506,000
Q1 2025 May 13, 2025	BUY	$1.07 - $2.03 $97,441 - $184,866	91,067 Added 21.62%	512,307 $763,000
Q4 2024 Feb 14, 2025	BUY	$0.67 - $1.12 $215,549 - $360,321	321,716 Added 323.25%	421,240 $471,000
Q3 2024 Nov 14, 2024	BUY	$0.91 - $1.88 $9,538 - $19,706	10,482 Added 11.77%	99,524 $94,000

Q2 2024 Aug 13, 2024	SELL	$1.27 - $1.75 $102,708 - $141,527	-80,873 Reduced 47.6%	89,042 $140,000
Q1 2024 May 13, 2024	SELL	$1.21 - $1.75 $54,015 - $78,121	-44,641 Reduced 20.81%	169,915 $246,000
Q4 2023 Feb 09, 2024	BUY	$0.89 - $1.41 $155,603 - $246,517	174,835 Added 440.16%	214,556 $287,000
Q3 2023 Nov 09, 2023	SELL	$1.08 - $1.85 $88,909 - $152,299	-82,324 Reduced 67.45%	39,721 $56,000
Q2 2023 Aug 11, 2023	BUY	$0.96 - $1.4 $27,115 - $39,543	28,245 Added 30.11%	122,045 $140,000
Q1 2023 May 12, 2023	BUY	$0.88 - $2.19 $43,897 - $109,243	49,883 Added 113.58%	93,800 $99,000
Q4 2022 Feb 08, 2023	SELL	$1.27 - $2.26 $4,001 - $7,121	-3,151 Reduced 6.69%	43,917 $66,000
Q3 2022 Nov 10, 2022	BUY	$1.41 - $2.79 $16,047 - $31,752	11,381 Added 31.89%	47,068 $99,000
Q2 2022 Aug 10, 2022	SELL	$1.15 - $2.53 $4,342 - $9,553	-3,776 Reduced 9.57%	35,687 $48,000
Q1 2022 May 16, 2022	SELL	$1.91 - $3.98 $881,189 - $1.84 Million	-461,356 Reduced 92.12%	39,463 $83,000
Q4 2021 Feb 14, 2022	BUY	$3.53 - $5.5 $761,894 - $1.19 Million	215,834 Added 75.74%	500,819 $1.86 Million
Q3 2021 Nov 15, 2021	BUY	$4.99 - $6.55 $857,785 - $1.13 Million	171,901 Added 152.01%	284,985 $1.42 Million
Q2 2021 Aug 13, 2021	SELL	$6.24 - $8.22 $944,642 - $1.24 Million	-151,385 Reduced 57.24%	113,084 $738,000
Q1 2021 May 12, 2021	BUY	$6.74 - $10.95 $1.02 Million - $1.66 Million	151,895 Added 134.93%	264,469 $1.82 Million
Q4 2020 Feb 11, 2021	SELL	$3.75 - $10.56 $136,248 - $383,676	-36,333 Reduced 24.4%	112,574 $1.15 Million
Q3 2020 Nov 12, 2020	BUY	$3.5 - $6.2 $50,050 - $88,660	14,300 Added 10.62%	148,907 $522,000
Q2 2020 Jul 31, 2020	BUY	$2.16 - $5.46 $16,843 - $42,577	7,798 Added 6.15%	134,607 $671,000
Q1 2020 May 01, 2020	BUY	$1.46 - $7.19 $185,141 - $911,756	126,809 New	126,809 $431,000

Others Institutions Holding PGEN

# of Institutions

188

Shares Held

194M

Call Options Held

6.61M

Put Options Held

2.06M

View Full List

About PRECIGEN, INC.

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $960M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

More about PGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account